Cerevel Therapeutics
在场
Cerevel Therapeutics 的所有者是 AbbVie.
是其中之一......
- Forbes Global 2000 (#89);
- Fortune 500 (#77);
- Global Fortune 500 (#259);
- Russell 3000;
- S&P 500;
- TOB Iconic 10,000.
AbbVie 是一家在股票代码 ABBV (US) 下上市的公司。
AbbVie 在 23 个国家有直接业务。AbbVie 拥有 34家子公司，其中包括 AbbVie APAC、AbbVie Australia 和 AbbVie Belgium。
他们在：
涉及AbbVie的并购和融资。
高管
查看带有其 30 名主要高管的组织结构图
Cerevel Therapeutics 搜索最多的简介
- Ron Renaud, President and Chief Executive Officer
- Chris Gordon, Director
- Deborah Baron, Independent Director
高管在Cerevel Therapeutics变化
- Ron Renaud, Director, President and Chief Executive Officer, 已经离开公司 (新闻发布的2024十月4号).
- Paul Burgess, Chief Business Development and Strategic Operations Officer, 已经离开公司 (新闻发布的2024十月4号).
高管在AbbVie变化
- Thomas Hudson, Senior Vice President, R&D and Chief Scientific Officer, 正在办理退休 (新闻发布的2024七月10号).
- Roxanne Austin 曾任 Director, 将于 20247月1 升职为 Lead Independent Director (新闻发布的2024六月21号).
创建提醒
跟踪 Cerevel Therapeutics 的高管变动
生物技术
AbbVie 拥有 2,327 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- Chromocell的新名称是Channel Therapeutics Corporation。 (公布2024十一月22号).
- Enveda Biosciences 刚刚宣布为 130 筹款数百万美元。 (公布2024十一月22号).
- Alentis Therapeutics 刚刚宣布为 181 筹款数百万美元。 (公布2024十一月20号).
生物技术 行业的其他推荐联系人
消息
Cerevel Therapeutics 的最新新闻稿
- Cerevel Therapeutics to Host Investor Webcast on Tavapadon in Parkinson’s Disease | Cerevel Therapeutics
- AbbVie to Acquire Cerevel Therapeutics in Transformative Transaction to Strengthen Neuroscience Pipeline | Cerevel Therapeutics
- Cerevel Therapeutics Announces Positive Topline Results for Tavapadon in Phase 3 Adjunctive Trial for People Living with Parkinson’s Disease | Cerevel Therapeutics
- Cerevel Therapeutics to Present at Upcoming Investor Conferences | Cerevel Therapeutics
- Cerevel Therapeutics Announces Pricing of $450 Million Public Offering of Common Stock | Cerevel Therapeutics
- Cerevel Therapeutics to Report Third Quarter 2023 Financial Results and Business Updates on Wednesday, November 1, 2023 | Cerevel Therapeutics
- Cerevel Therapeutics Reports Third Quarter 2023 Financial Results and Business Updates | Cerevel Therapeutics
- Cerevel Therapeutics to Present at Morgan Stanley 21st Annual Global Healthcare Conference | Cerevel Therapeutics
- Cerevel Therapeutics Reports Second Quarter 2023 Financial Results and Business Updates | Cerevel Therapeutics
- Cerevel Therapeutics to Report Second Quarter 2023 Financial Results and Business Updates on Wednesday, August 2, 2023 | Cerevel Therapeutics
- View more press releases Close
通过电子邮件
